Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20709233 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes
Condition: Cardiovascular Disease
Interventions: Drug: rimonabant (SR141716);   Drug: placebo

Indicates status has not been verified in more than two years